Sr. Director
Amgen
Wenny Du, RAC, MS, MBA, is Senior Director and Global Regulatory Lead (GRL) for Oncology at Amgen Inc. (California). In this role, she leads global regulatory teams in the development and execution of strategies to secure approvals for Amgen’s innovative oncology therapies, helping bring transformative medicines to patients around the world.
With over 25 years of experience in the biopharmaceutical industry, Wenny has held leadership roles across China, the Asia Pacific region, and global functions in the U.S. Her expertise spans regulatory affairs, clinical development, marketing, and program management. She has successfully led approximately 15 new product approvals, along with numerous indication approvals and product launches. She is particularly skilled in orchestrating simultaneous global drug development, regulatory filings, and approvals.
Wenny holds a Master of Science in Regulatory Science from Johns Hopkins University, an MBA from China Europe International Business School (CEIBS), and a Bachelor of Engineering in Biopharmaceutics from China Pharmaceutical University (CPU). She is currently pursuing a Doctorate in Regulatory Science at the University of Southern California (USC). In addition, she holds the U.S. Regulatory Affairs Certification (RAC) and is a certified Lean Six Sigma Black Belt from the Georgia Institute of Technology (Georgia Tech).
China Drug Regulatory Pathways: 2025 Current Landscape & Global Integration Perspectives
Thursday, October 9, 2025
3:15 PM - 4:15 PM EST